Clinical Trial Details
EORTC-1621-QLG-LG
Back to Clinical Trials Database
A Survivorship Project to understAnd and to impRove long-Term outcomes for Acute myeloid leukemia patients (SPARTA): The SPARTA Platform
| Trial Status | Closed to Patient Entry |
|---|---|
| Dates |
Date of activation: 02-Jul-2020 |
| Data management at EORTC | No |
| Design |
Cohort Not randomized / N.A. |
| Targeted Sample size | EORTC Groups: 100 - All Groups: 343 |
| Treatment |
None |
| Study Staff |
Frederic Baron (Study Coordinator) , C.H.U. Sart-Tilman, Liege Fabio Efficace (Study Coordinator) , GIMEMA Centro Dati, Roma Melanie Beauvois (Clinical Operations Manager) , EORTC Headquarters, Brussels Corneel Coens (Statistician) , EORTC Headquarters, Brussels Gilles Sarlet (Regulatory Affairs Manager) , EORTC Headquarters, Brussels |
| Type of cancer | Acute Myelogenous Leukemia |
| Participating groups |
EORTC Leukemia Group EORTC Quality of Life Group Gruppo Italiano Malattie Ematologiche dell'Adulto |
| Recruiting centers |
Ankara University School Of Medicine - Cebeci Campus (Ankara, Turkey) Azienda Ospedaliera Universitaria - Policlinico Tor Vergata (Roma, Italy) C.H.U. Sart-Tilman (Liege, Belgium) CHU de Lyon - Hopital Lyon Sud (PIERRE BENITE CEDEX, France) Centre Hospitalier Regional De La Citadelle (Liege, Belgium) Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Roma, Italy) Universita Degli Studi Di Roma La Sapienza - Ospedale Sant'Andrea (Roma, Italy) University Clinic of Hematology (Skopje, Macedonia) University Medical Centre Ljubljana (Ljubljana, Slovenia) |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number | |
| Financial Support | EORTC Group |
